Obesity and schizophrenia: results of a feasibility study with semaglutide to assist weight loss [abstract only]

Heald, A.; Reynolds, Gavin; Nash, I.; Boyle, O.; Daly, C.; Longson, D.; Shi, L.; Stedman, M.; Syed, A.

Obesity and schizophrenia: results of a feasibility study with semaglutide to assist weight loss [abstract only]

Tools

HEALD, A., REYNOLDS, Gavin, NASH, I., BOYLE, O., DALY, C., LONGSON, D., SHI, L., STEDMAN, M. and SYED, A. (2026). Obesity and schizophrenia: results of a feasibility study with semaglutide to assist weight loss [abstract only]. Neuroscience Applied, 5 (Supp 1): 105758. [Article]

[+][-]

Documents

36642:1147180

[+][-]

36642:1147180

[thumbnail of Reynolds-ObesityAndSchizophrenia(VoR-abstract).pdf]

Preview

PDF
Reynolds-ObesityAndSchizophrenia(VoR-abstract).pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (84kB) | Preview

More Information

Official URL:

https://www.sciencedirect.com/science/article/pii/...

Open Access URL:

https://pdf.sciencedirectassets.com/780146/1-s2.0-...

Open Access Version:

Published version

Additional Information:

** Article version: VoR ** From Elsevier via Jisc Publications Router ** History: epub 02-01-2026; issued 31-12-2026. ** Licence for VoR version of this article starting on 17-11-2025: http://creativecommons.org/licenses/by-nc-nd/4.0/

Identifiers

Identification Number:

10.1016/j.nsa.2025.105758

ORCID for Gavin Reynolds: